acute toxicity; animal experiment; animal model; antiviral activity; article; body weight; body weight gain; clinical chemistry; controlled study; coronavirus disease 2019; drug toxicity; hemagglutination inhibition; hematology; herbal medicine; Influenza A virus (H5N1); LD50; Leporidae; male; microcapsule; mouse; no-observed-adverse-effect level; nonhuman; Organisation for Economic Co-operation and Development; plaque reduction neutralization test; practice guideline; Severe acute respiratory syndrome coronavirus 2; antivirus agent